Finance

Lists
Why is DCOY down 4,80%?
Dive Deeper
DCOY:NASDAQ
Decoy Therapeutics Inc
1,18 USD
-4,80%
(-0,059) 1D
14-окт., 12:22:11 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DCOY...
Open
1,27 USD
High
1,27 USD
Low
1,16 USD
Mkt. cap
773,45 миң
Avg. vol.
4,57 млн
Volume
54,44 миң
52-wk high
16,92 USD
52-wk low
1,16 USD
EPS
-934,20 USD
Beta
0,65
Shares outstanding
2,38 млн
No. of employees
11
Open
1,27 USD
High
1,27 USD
Low
1,16 USD
Mkt. cap
773,45 миң
Avg. vol.
4,57 млн
Volume
54,44 миң
52-wk high
16,92 USD
52-wk low
1,16 USD
EPS
-934,20 USD
Beta
0,65
Shares outstanding
2,38 млн
No. of employees
11
News stories
From web sources and news partners
About Decoy Therapeutics Inc
CEO-
Employees11
Founded2014
HeadquartersХьюстон, Техас, Америка Кошмо Штаттары
Sector-
Analyst
Recommendation
Action
Price target
Projected
Date
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
2,50 USD
+111,8%
01/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
227,63 миң
Cost of goods sold
-
-
-
1,30 млн
Cost of revenue
-
-
-
1,30 млн
Research and development expenses
61,83 миң
114,43 миң
749,81 миң
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
833,30 миң
402,17 миң
1,53 млн
1,33 млн
Operating expense
895,13 миң
516,60 миң
2,28 млн
1,33 млн
Total operating expenses
895,13 миң
516,60 миң
2,28 млн
2,63 млн
Operating income
-895,13 миң
-516,60 миң
-2,28 млн
-2,40 млн
Other non operating income
-
-
-
-
EBT including unusual items
-873,47 миң
-8,98 млн
-2,22 млн
-2,37 млн
EBT excluding unusual items
-873,47 миң
-459,69 миң
-2,22 млн
-2,37 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-873,47 миң
-8,98 млн
-2,22 млн
-2,37 млн
Net profit margin
-
-
-
-1 042,84%
Earnings per share
-
43,10
-4,18
-
Interest and investment income
21,66 миң
56,91 миң
59,11 миң
29,59 миң
Interest expense
-
-
-
-
Net interest expenses
21,66 миң
56,91 миң
59,11 миң
29,59 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-894,02 миң
-512,76 миң
-2,28 млн
-2,39 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору